New York, NY (January 15, 2021) \u2013 At the Committee of 100\u2019s Annual Meeting of Members, a new team of Officers and Directors were elected to help lead the organization in 2021 and beyond.<\/p>\n
Former Secretary of Commerce, U.S. Ambassador to China, and Governor of Washington State\u00a0Gary Locke<\/strong><\/a>\u00a0was elected by members as Chair-Elect, and will take over as Chairman from\u00a0H. Roger Wang<\/strong><\/a>\u00a0at the May 2021 Annual Meeting.<\/p>\n Serving with Gary on the senior leadership team will be\u00a0Charlie Woo<\/strong><\/a>, co-founder and CEO of Megatoys, who was elected as Vice-Chair;\u00a0John Chiang<\/strong><\/a>, former California State Treasurer, who was elected as Chief Financial Officer and\u00a0Wilson Chu<\/strong><\/a>, partner in the law firm of McDermott Will & Emery LLP, who was re-elected as General Counsel & Secretary.<\/p>\n \u201cI am excited about the energy, passion and commitment Gary Locke and the leadership team will bring to their roles and keep the Committee of 100 top of mind on issues surrounding Chinese Americans,\u201d said H. Roger Wang. \u201cWhen my term as Chairman comes to a close, I\u2019ll look forward to continuing my active involvement in Committee of 100 and supporting the team in any way I can. I\u2019ve been honored to hold the position with great respect and reverence.\u201d<\/p>\n In addition to the Officer roles, a series of new Directors were elected to begin their own three-year terms as Board Members. The Committee of 100 Board is a total of 17 members.<\/p>\n In addition to Gary Locke, the new Board Member Directors for 2021-2023 include: All Committee of 100 Directors and Officers are Members of the organization. Committee of 100 holds elections for Chairman every three years.<\/p>\n","protected":false},"excerpt":{"rendered":" New York, NY (January 15, 2021)...<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-30727","post","type-post","status-publish","format-standard","hentry","category-u-s-a"],"_links":{"self":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/30727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30727"}],"version-history":[{"count":1,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/30727\/revisions"}],"predecessor-version":[{"id":30728,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/30727\/revisions\/30728"}],"wp:attachment":[{"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nRichard Lee<\/strong><\/a>, Chairman and CEO of Amsino Medical Group;\u00a0Mei-Mei Tuan<\/strong><\/a>, Founder and Managing Partner of Phoenyx Partners;\u00a0Debra Wong Yang<\/strong><\/a>, Partner at Gibson, Dunn & Crutcher; and\u00a0Nancy Yuan<\/strong><\/a>, Senior Vice President and Director, Washington of The Asia Foundation.\u00a0Philip Ma<\/strong><\/a>, Chief Executive Officer, President, and Founder of PrognomiQ was elected to his second three-year term as Director.<\/p>\n